Document Classification

Section Type: RESULTS

Text: Following rifaximin, platelet counts increased significantly (83 100 9700 vs. 99 600 11 200/l ; P = 0. 006) in line with significant reductions in endotoxin (1. 28 0. 41 vs. 2. 54 0. 86 EU/ml ; P = 0. 005), IL-1 (3. 1 0. 5 vs. 4. 4 1. 2 pg/ml ; P = 0. 04), IL-6 (12. 8 2. 5 vs. 21. 1 4. 2 pg/ml ; P = 0. 01) and TNF - (3. 6 1. 3 vs. 5. 8 1. 7 ; P = 0. 02) levels.